Cargando…

Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease

Considering the progressive prevalence and co-occurrence of type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD), as well as the current evidence suggesting the elevated levels of basal metabolic rate (BMR) among these individuals, the present study aimed to identify factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mansour, Asieh, Motamed, Soudabe, Hekmatdoost, Azita, Karimi, Sara, Mohajeri-Tehrani, Mohammad Reza, Abdollahi, Mohammad, Jelodar, Reihane, Sajjadi-Jazi, Sayed Mahmoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985614/ https://www.ncbi.nlm.nih.gov/pubmed/36871124 http://dx.doi.org/10.1038/s41598-023-30945-w

Ejemplares similares

Vitamin D supplementation in COVID-19: A friend or foe?
por: Mansour, Asieh, et al.
Publicado: (2020)

Short term effects of coffee components consumption on gut microbiota in patients with non-alcoholic fatty liver and diabetes: A pilot randomized placebo-controlled, clinical trial
por: Mansour, Asieh, et al.
Publicado: (2020)

Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial
por: Mansour, Asieh, et al.
Publicado: (2021)

Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population
por: Mansour, Asieh, et al.
Publicado: (2023)

Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
por: Salavatizadeh, Marieh, et al.
Publicado: (2023)

Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome
por: Mansour, Asieh, et al.
Publicado: (2022)

Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease
por: Saadati, Saeede, et al.
Publicado: (2018)

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
por: Saadati, Saeede, et al.
Publicado: (2019)

Dietary total antioxidant capacity is inversely associated with the odds of non-alcoholic fatty liver disease in people with type-2 diabetes
por: Salavatizadeh, Marieh, et al.
Publicado: (2022)

The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM)
por: Soltanieh, Samira, et al.
Publicado: (2023)

Clinical characteristics and outcomes of diabetics hospitalized for COVID-19 infection: a single-centered, retrospective, observational study
por: Mansour, Asieh, et al.
Publicado: (2020)

Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism
por: Emamat, Hadi, et al.
Publicado: (2020)

Factitious Hypoglycemia Caused by a Unique Pattern of Drug Use: A Case Report
por: Akbari, Mojtaba, et al.
Publicado: (2017)

Adherence to oxidative balance scores and lower odds of non-alcoholic fatty liver disease: a case–control study
por: Sohouli, Mohammad Hassan, et al.
Publicado: (2023)

Egg consumption and risk of non-alcoholic fatty liver disease
por: Mokhtari, Zeinab, et al.
Publicado: (2017)

Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome
por: Mansour, Asieh, et al.
Publicado: (2016)

The Association between Nuts Intake and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: a Case-Control Study
por: Asbaghi, Omid, et al.
Publicado: (2020)

Red and Processed Meat Intake in Relation to Non-Alcoholic Fatty Liver Disease Risk: Results from a Case-Control Study
por: Rahimi-Sakak, Fatemeh, et al.
Publicado: (2022)

Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control study
por: Emamat, Hadi, et al.
Publicado: (2021)

Vitamin D and biomarkers of inflammation and oxidative stress among pregnant women: a systematic review of observational studies
por: Motamed, Soudabe, et al.
Publicado: (2023)

The association between epicardial adipose tissue and non-alcoholic fatty liver disease: A systematic review of existing human studies
por: Emamat, Hadi, et al.
Publicado: (2021)

Design, synthesis, and cytotoxic evaluation of quinazoline derivatives bearing triazole-acetamides
por: Pedrood, Keyvan, et al.
Publicado: (2023)

Dietary Total Antioxidant Capacity and Risk of Non-Alcoholic Fatty Liver Disease: A Case‐Control Study
por: Salehi-Sahlabadi, Ammar, et al.
Publicado: (2020)

What is “Hyper” in the ALS Hypermetabolism?
por: Ferri, Alberto, et al.
Publicado: (2017)

Hypermetabolic pseudotumour of the chest wall
por: Kamal, Yasser Ali, et al.
Publicado: (2020)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Nutrient patterns and non-alcoholic fatty liver disease in Iranian Adul: A case-control study
por: Salehi-sahlabadi, Ammar, et al.
Publicado: (2022)

The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial
por: Qorbani, Mostafa, et al.
Publicado: (2020)

Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial
por: Shavakhi, Ahmad, et al.
Publicado: (2013)

Congenital hypermetabolism and uncoupled oxidative phosphorylation
por: Ganetzky, Rebecca D., et al.
Publicado: (2022)

Modulation of Burn Hypermetabolism in Preclinical Models
por: Eldaly, Abdullah S, et al.
Publicado: (2023)

Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
por: Yari, Zahra, et al.
Publicado: (2023)

The effect of vitamin D supplementation on oxidative stress and inflammatory biomarkers in pregnant women: a systematic review and meta-analysis of clinical trials
por: Motamed, Soudabe, et al.
Publicado: (2022)

Adherence to a Paleolithic Diet in Combination With Lifestyle Factors Reduces the Risk for the Presence of Non-Alcoholic Fatty Liver Disease: A Case-Control Study
por: Sohouli, Mohammad Hassan, et al.
Publicado: (2022)

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial
por: Darabi, Zahra, et al.
Publicado: (2019)

Comments on “The Effects of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease”
por: Cheraghpour, Makan, et al.
Publicado: (2016)

Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease
por: Naseri, Kaveh, et al.
Publicado: (2022)

Burn size determines the inflammatory and hypermetabolic response
por: Jeschke, Marc G, et al.
Publicado: (2007)

Effect of celecoxib in treatment of burn-induced hypermetabolism
por: Zhuang, Shubo, et al.
Publicado: (2020)

43 Mapping the Hypermetabolic Response in Burn Patients
por: Knuth, Carly M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sduuu4jghilss3f18uis96mu5o